 | • レポートコード：MRC2303F0207 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、244ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：材料 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートは、2021年に224.2億ドルであった世界の使い捨てバイオプロセシング市場規模が、2022年に298.9億ドルになり、2027年まで年平均33.47%で成長して1,268.2億ドルに拡大すると予測しています。本レポートでは、使い捨てバイオプロセシングの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、機能別（細胞培養、ろ過、混合、精製、保存）分析、製品別（バイオプロセスドラムライナー＆付属品、使い捨てミキサー、使い捨てバイオリアクター、ろ過アセンブリ、流体移送アセンブリ）分析、ワークフロー別（ダウンストリーム、発酵、アップストリーム）分析、エンドユーザー別（学術＆研究機関、製造受託機関、受託研究機関、薬＆バイオテクノロジー企業）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目を掲載しています。また、主要企業として、AGC Inc、Boehringer Ingelheim GmbH、Cesco Bioengineering Company、Corning Incorporated、Danaher Corporation、ENTEGRIS, INC.、Eppendorf AG、GE healthcare、Getinge、Infors AG、JM BIOCONNECT、Kuhner AG、Lonza Group AG、Meissner Filtration Products, Inc.、Merck KGaA、Octane Biotech Inc.、Parker-Hannifin Corporation、PBS Biotech, Inc、PendoTECH, LLC、Rentschler Biopharma SE、Sartorius AG、Sentinel Process Systems Inc.などの企業情報を含んでいます。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の使い捨てバイオプロセシング市場規模：機能別 - 細胞培養機能のバイオプロセシング市場規模 - ろ過機能のバイオプロセシング市場規模 - 混合機能のバイオプロセシング市場規模 - 精製機能のバイオプロセシング市場規模 - 保存機能のバイオプロセシング市場規模 ・世界の使い捨てバイオプロセシング市場規模：製品別 - バイオプロセスドラムライナー＆付属品の市場規模 - 使い捨てミキサーの市場規模 - 使い捨てバイオリアクターの市場規模 - ろ過アセンブリの市場規模 - 流体移送アセンブリの市場規模 ・世界の使い捨てバイオプロセシング市場規模：ワークフロー別 - ダウンストリームにおける市場規模 - 発酵における市場規模 - アップストリームにおける市場規模 ・世界の使い捨てバイオプロセシング市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 製造受託機関における市場規模 - 受託研究機関における市場規模 - 薬＆バイオテクノロジー企業における市場規模 ・世界の使い捨てバイオプロセシング市場規模：地域別 - 南北アメリカの使い捨てバイオプロセシング市場規模 アメリカの使い捨てバイオプロセシング市場規模 カナダの使い捨てバイオプロセシング市場規模 ブラジルの使い捨てバイオプロセシング市場規模 ... - アジア太平洋の使い捨てバイオプロセシング市場規模 日本の使い捨てバイオプロセシング市場規模 中国の使い捨てバイオプロセシング市場規模 インドの使い捨てバイオプロセシング市場規模 韓国の使い捨てバイオプロセシング市場規模 台湾の使い捨てバイオプロセシング市場規模 ... -ヨーロッパ/中東/アフリカの使い捨てバイオプロセシング市場規模 イギリスの使い捨てバイオプロセシング市場規模 ドイツの使い捨てバイオプロセシング市場規模 フランスの使い捨てバイオプロセシング市場規模 ロシアの使い捨てバイオプロセシング市場規模 ... -その他地域の使い捨てバイオプロセシング市場規模 ・競争状況 ・企業情報 |
The Global Single-use Bioprocessing Market size was estimated at USD 22.42 billion in 2021 and expected to reach USD 29.89 billion in 2022, and is projected to grow at a CAGR 33.47% to reach USD 126.82 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Single-use Bioprocessing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Function, the market was studied across Cell Culture, Filtration, Mixing, Purification, and Storage.
Based on Product, the market was studied across Bioprocess Drums Liners and Accessories, Disposable Mixers, Disposable/Single-Use Bioreactors, Filtration Assemblies, Fluid Transfer Assemblies, Media Bags and Containers, and Tubing, Connectors, and Samplers.
Based on Workflow, the market was studied across Downstream, Fermentation, and Upstream.
Based on End User, the market was studied across Academic & Research Institutes, Contract Manufacturing Organizations, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Single-use Bioprocessing market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Single-use Bioprocessing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Single-use Bioprocessing Market, including AGC Inc, Boehringer Ingelheim GmbH, Cesco Bioengineering Company, Corning Incorporated, Danaher Corporation, ENTEGRIS, INC., Eppendorf AG, GE healthcare, Getinge, Infors AG, JM BIOCONNECT, Kuhner AG, Lonza Group AG, Meissner Filtration Products, Inc., Merck KGaA, Octane Biotech Inc., Parker-Hannifin Corporation, PBS Biotech, Inc, PendoTECH, LLC, Rentschler Biopharma SE, Sartorius AG, Sentinel Process Systems Inc., Sigma-Aldrich Co. LLC, The 3M Company, Thermo Fisher Scientific, Inc., and Watson-Marlow Fluid Technology Group.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Single-use Bioprocessing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Single-use Bioprocessing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Single-use Bioprocessing Market?
4. What is the competitive strategic window for opportunities in the Global Single-use Bioprocessing Market?
5. What are the technology trends and regulatory frameworks in the Global Single-use Bioprocessing Market?
6. What is the market share of the leading vendors in the Global Single-use Bioprocessing Market?
7. What modes and strategic moves are considered suitable for entering the Global Single-use Bioprocessing Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand in pre-commercial manufacturing involved in preclinical and clinical scales
5.1.1.2. Increasing adoption of single-use technology amongst CMOs
5.1.1.3. Rise in adoption of disposable technologies
5.1.1.4. Low risk of product cross-contamination associated to SUB technologies
5.1.2. Restraints
5.1.2.1. Issues linked with leachables and extractables
5.1.3. Opportunities
5.1.3.1. Single-use bioprocessing integration of big data-based machine learning
5.1.3.2. Growing interest of investors to fund for innovative technologies and R&D activities
5.1.4. Challenges
5.1.4.1. Limited enactment in downstream processing
5.1.4.2. Stringent regulations pertaining to use of disposable systems
5.2. Cumulative Impact of COVID-19
6. Single-use Bioprocessing Market, by Function
6.1. Introduction
6.2. Cell Culture
6.3. Filtration
6.4. Mixing
6.5. Purification
6.6. Storage
7. Single-use Bioprocessing Market, by Product
7.1. Introduction
7.2. Bioprocess Drums Liners and Accessories
7.3. Disposable Mixers
7.4. Disposable/Single-Use Bioreactors
7.5. Filtration Assemblies
7.6. Fluid Transfer Assemblies
7.7. Media Bags and Containers
7.8. Tubing, Connectors, and Samplers
8. Single-use Bioprocessing Market, by Workflow
8.1. Introduction
8.2. Downstream
8.3. Fermentation
8.4. Upstream
9. Single-use Bioprocessing Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Manufacturing Organizations
9.4. Contract Research Organizations
9.5. Pharmaceutical & Biotechnology Companies
10. Americas Single-use Bioprocessing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Single-use Bioprocessing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Single-use Bioprocessing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AGC Inc
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Boehringer Ingelheim GmbH
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Cesco Bioengineering Company
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Corning Incorporated
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Danaher Corporation
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. ENTEGRIS, INC.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Eppendorf AG
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. GE healthcare
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Getinge
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Infors AG
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. JM BIOCONNECT
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Kuhner AG
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Lonza Group AG
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Meissner Filtration Products, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Merck KGaA
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Octane Biotech Inc.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. Parker-Hannifin Corporation
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. PBS Biotech, Inc
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. PendoTECH, LLC
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Rentschler Biopharma SE
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Sartorius AG
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
14.22. Sentinel Process Systems Inc.
14.22.1. Business Overview
14.22.2. Key Executives
14.22.3. Product & Services
14.23. Sigma-Aldrich Co. LLC
14.23.1. Business Overview
14.23.2. Key Executives
14.23.3. Product & Services
14.24. The 3M Company
14.24.1. Business Overview
14.24.2. Key Executives
14.24.3. Product & Services
14.25. Thermo Fisher Scientific, Inc.
14.25.1. Business Overview
14.25.2. Key Executives
14.25.3. Product & Services
14.26. Watson-Marlow Fluid Technology Group
14.26.1. Business Overview
14.26.2. Key Executives
14.26.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing